Cencora Management

Management Kriterienprüfungen 3/4

Cencora's CEO ist Steve Collis , ernannt in Nov 2010, hat eine Amtszeit von 13.58 Jahren. Die jährliche Gesamtvergütung beträgt $17.51M , bestehend aus 8% Gehalt und 92% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.14% der Aktien des Unternehmens, im Wert von $66.91M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.4 Jahre bzw. 9.1 Jahre.

Wichtige Informationen

Steve Collis

Geschäftsführender

US$17.5m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	8.0%
Amtszeit als Geschäftsführer	13.8yrs
Eigentum des Geschäftsführers	0.1%
Durchschnittliche Amtszeit des Managements	5.8yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	9.3yrs

Jüngste Management Updates

Recent updates

Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Sep 18

Cencora: Credentials To Die For, But Underlying Issues Make Case For 'Hold' Rating

Sep 18

Market Participants Recognise Cencora, Inc.'s (NYSE:COR) Earnings

Jul 16

Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning

Jun 30

Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Mar 18

Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Feb 25

Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Feb 07

Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price

Jan 05

Cencora: Continued Economic Value On The Table Across All Investment Horizons

Jan 04

A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)

Dec 15

Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year

Nov 05

Is Cencora (NYSE:COR) A Risky Investment?

Nov 03

Cencora: New Name, Same Old Economic Leverage, Reiterate Buy

Oct 18

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

Aug 01

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

Jul 28

We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

Jun 19

Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?

May 01

Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching

Apr 10

AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet

Mar 02

AmerisourceBergen declares $0.485 dividend

Feb 01

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Jan 28

AmerisourceBergen partners with pharmaceutical company Civica

Jan 23

AmerisourceBergen: What Does The Valuation Look Like After The Recent Price Rise?

Jan 13

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Steve Collis im Vergleich zu den Einnahmen von Cencora verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Jun 30 2024	n/a	n/a	US$2b
Mar 31 2024	n/a	n/a	US$2b
Dec 31 2023	n/a	n/a	US$2b
Sep 30 2023	US$18m	US$1m	US$2b
Jun 30 2023	n/a	n/a	US$2b
Mar 31 2023	n/a	n/a	US$2b
Dec 31 2022	n/a	n/a	US$2b
Sep 30 2022	US$17m	US$1m	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	n/a	n/a	US$2b
Sep 30 2021	US$15m	US$1m	US$2b
Jun 30 2021	n/a	n/a	-US$4b
Mar 31 2021	n/a	n/a	-US$4b
Dec 31 2020	n/a	n/a	-US$3b
Sep 30 2020	US$14m	US$1m	-US$3b
Jun 30 2020	n/a	n/a	US$2b
Mar 31 2020	n/a	n/a	US$2b
Dec 31 2019	n/a	n/a	US$649m
Sep 30 2019	US$11m	US$1m	US$855m
Jun 30 2019	n/a	n/a	US$956m
Mar 31 2019	n/a	n/a	US$930m
Dec 31 2018	n/a	n/a	US$1b
Sep 30 2018	US$12m	US$1m	US$2b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$855m
Dec 31 2017	n/a	n/a	US$979m
Sep 30 2017	US$10m	US$1m	US$364m

Vergütung im Vergleich zum Markt: SteveDie Gesamtvergütung ($USD17.51M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD13.41M).

Entschädigung vs. Einkommen: SteveDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Steve Collis (63 yo)

13.8yrs

Amtszeit

US$17,511,240

Vergütung

Mr. Steven H. Collis, also known as Steve, has been the Chief Executive Officer and President of Cencora, Inc. (formerly known as AmerisourceBergen Corporation) since July 2011 and November 2010 respective...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Steven Collis	Chairman	13.8yrs	US$17.51m	0.15% $ 64.1m
James Cleary	Executive VP & CFO	5.8yrs	US$5.45m	0.058% $ 25.7m
Robert Mauch	Executive VP & COO	1.9yrs	US$7.70m	0.012% $ 5.5m
Gina Clark	Executive VP and Chief Communications & Administration Officer	7.3yrs	US$3.17m	0.0068% $ 3.0m
Elizabeth Campbell	Executive VP & Chief Legal Officer	3yrs	US$4.03m	0.0042% $ 1.9m
Lazarus Krikorian	Senior VP	12.7yrs	keine Daten	0.010% $ 4.5m
Bennett Murphy	Senior Vice President of Investor Relations	no data	keine Daten	keine Daten
Jennifer Dubas	Senior VP & Chief Compliance Officer	no data	keine Daten	keine Daten
Silvana Battaglia	Executive VP & Chief Human Resources Officer	5.7yrs	US$3.48m	0.0056% $ 2.5m
Ann Anaya	Senior VP and Chief Diversity Equity & Inclusion Officer	2.7yrs	keine Daten	keine Daten
J. Quinn	VP & Corporate Treasurer	no data	keine Daten	keine Daten
Brian Nightengale	President of Good Neighbor Pharmacy	8.1yrs	keine Daten	keine Daten

5.8yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrenes Management: CORDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.4 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Steven Collis	Chairman	13.3yrs	US$17.51m	0.15% $ 64.1m
Lauren Tyler	Independent Director	less than a year	keine Daten	keine Daten
Richard Gochnauer	Independent Director	16yrs	US$300.10k	0.011% $ 5.1m
Mark M. Durcan	Lead Independent Director	9yrs	US$380.05k	0.010% $ 4.4m
Lon Greenberg	Independent Director	11.3yrs	US$332.60k	0.0057% $ 2.5m
Kathleen Hyle	Independent Director	14.3yrs	US$320.10k	0.011% $ 4.7m
Dennis Nally	Independent Director	4.7yrs	US$375.36k	0.0044% $ 2.0m
Ornella Barra	Director	9.7yrs	keine Daten	keine Daten
Henry McGee	Independent Director	19.8yrs	US$320.10k	0.0077% $ 3.4m
Werner Baumann	Independent Director	less than a year	keine Daten	keine Daten
Lorence Kim	Independent director	1.9yrs	US$397.33k	0.000090% $ 39.7k
Redonda Miller	Independent Director	1.7yrs	US$311.82k	0.00080% $ 352.7k

9.3yrs

Durchschnittliche Betriebszugehörigkeit

64yo

Durchschnittliches Alter

Erfahrener Vorstand: CORDie Vorstandsmitglieder gelten als erfahren (9.1 Jahre durchschnittliche Amtszeit).

Cencora Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

Chairman notifies of intention to sell stock

Chairman notifies of intention to sell stock

Cencora, Inc. Elects Frank Clyburn as New Independent Director, Effective October 1, 2024

Chairman notifies of intention to sell stock

Chairman notifies of intention to sell stock

Insider exercised options and sold US$3.5m worth of stock

Recent updates

Chairman notifies of intention to sell stock

Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Cencora: Credentials To Die For, But Underlying Issues Make Case For 'Hold' Rating

Chairman notifies of intention to sell stock

Cencora, Inc. Elects Frank Clyburn as New Independent Director, Effective October 1, 2024

Third quarter dividend of US$0.51 announced

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Cencora, Inc. Declares Quarterly Cash Dividend, Payable on August 26, 2024

Chairman notifies of intention to sell stock

Market Participants Recognise Cencora, Inc.'s (NYSE:COR) Earnings

Cencora, Inc. to Report Q3, 2024 Results on Jul 31, 2024

Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning

Are Investors Undervaluing Cencora, Inc. (NYSE:COR) By 43%?

Chairman notifies of intention to sell stock

Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Insider exercised options and sold US$3.5m worth of stock

Chairman exercised options and sold US$1.4m worth of stock

Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?

Second quarter dividend of US$0.51 announced

Cencora, Inc. Declares Quarterly Cash Dividend on Common Share, Payable on May 24, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Cencora, Inc. (NYSE:COR) announces an Equity Buyback for $2,000 million worth of its shares.

Executive VP & COO exercised options and sold US$4.9m worth of stock

Cencora, Inc. to Report Q2, 2024 Results on May 01, 2024

Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings

Cencora Remains Chronically Undervalued, With Material Growth Potential

Chairman exercised options and sold US$1.6m worth of stock

Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Cencora, Inc. Reaffirms Guidance for Year 2024

Cencora, Inc. Announces CEO Changes, Effective October 1, 2024

Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Cencora’s FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products

Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

First quarter dividend of US$0.51 announced

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 9.0% to US$235

Consensus EPS estimates fall by 14%

Cencora, Inc. Declares Quarterly Cash Dividend on Common Share, Payable on February 26, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Cencora, Inc. to Report Q1, 2024 Results on Jan 31, 2024

Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price

Cencora: Continued Economic Value On The Table Across All Investment Horizons

Chairman recently sold US$8.7m worth of stock

A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)

Chairman exercised options and sold US$3.1m worth of stock

Insider recently sold US$2.0m worth of stock

Executive VP & CFO exercised options and sold US$3.1m worth of stock

Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year

Cencora, Inc. Declares Quarterly Dividend, Payable November 27, 2023

Is Cencora (NYSE:COR) A Risky Investment?

Full year 2023 earnings: EPS misses analyst expectations

Cencora: New Name, Same Old Economic Leverage, Reiterate Buy

Chairman exercised options and sold US$2.7m worth of stock

Cencora, Inc. to Report Q4, 2023 Results on Nov 02, 2023

Insider exercised options and sold US$2.0m worth of stock

Now 20% undervalued after recent price drop

Chairman exercised options and sold US$1.0m worth of stock

Now 21% undervalued

Amerisourcebergen Corporation Elects Werner Baumann and Lauren Tyler to Its Board of Directors

Chairman notifies of intention to sell stock

AmerisourceBergen Corporation Declares Quarterly Cash Dividend, Payable on August 28, 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

Chairman notifies of intention to sell stock

AmerisourceBergen Corporation to Report Q3, 2023 Results on Aug 02, 2023

Insider exercised options and sold US$3.0m worth of stock

We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt